Skip to main content

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies.

Contact Details Of Pharma HRs :

Zaydus cadila-Goa
gajendravernekar@zayduscadila.com
09623458512/08326615143

Teva-Goa
Maryann.Braganza@teva.co.in
sanjay.pandit@teva.co.in
0832 6685538

Glenmark-Goa
Vittal hebbalkar hr executivr - 9923476869
anupbannatti@glenmark-generics.com
09604151586

Watson-Goa
Jyosna.bagule@watsonpharm.co.in
runa.divkar@watsonpharm.co.in
goa@watsonpharm.co.in
0832 6690666/777

Unichem Labs-Goa
abhiram.panshikar@unichemlabs.com
R&D 
suraj.jadhav@unichemlabs.com
vikas.parkar@unichemlabs.com

Indico-Goa
goahplc@Indoco.com
varun.keny@indoco.com
anand.ingole@Indoco.com
0832 6624109

Encube-Goa
hr@encubeethicals.com
nidhi.b@encubeethicals.com
8322392223

Torrent pharma-Ahmdabad
mayurdesai@torrentpharma.com
9879603921/22/23/24

Emcure-pune
RPKulkarni@emcure.co.in          
Kishor.Mule@emcure.co.in
Rahul.Morgaonkar@emcure.co.in
recruitment@emcure.co.in
hr.plantIII@emcure.co.in
Dastgir.Mujawar@emcure.co.in
02039821300

Centaur-Pune
hrpune@centaur.co.in
mpatil@centaur.co.in
020 66739460/00

Sandoz-Mumbai
satheesh.nair@sandoz.com
022 27639065

Flamingo-Mumbai
hr@flamingopharma.com
saloni.samani@flamingopharma.com
9324067298

Ajanta-Mumbai
Hareshwar.warude@ajantapharma.com
Inventiahealthcare-Mumbai
dharmendra.rajbhar@inventiahealthcare.com
022 6716 3452 / 3688

Lupin-Bhoisar
trhr@lupinpharma.com, dileepnair@lupinpharma.com

Ajanta Aurangabad
sridhar.tedulapu@ajantapharma.com
venkata.rao@ajantapharma.com
girish.shinde@ajantapharma.com
Nirmalplacement.hr@gmail.com
7385119561/ 02431664000

Wockhardt-Aurangabad
jwaghmode@wockhardt.com
eouhr@wockhardt.com
0240 6626455

Maylan-Aurangabad
sawti.thorat@Mylan.in
8888847799

Glenmark-Aurangabad
sanjaykulkarni@glenmarkpharma.com

Alembic Pharma
mansi.meheta@alembic.co.in

Hospira India, Vishkhapatnam
Suseela.Ruttala@hospira.com
mahesh.bv@hospira.com
0891 306642

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Intellectual Property Rights and Portfolio Management in Pharmaceuticals

  Introduction The pharmaceutical industry depends heavily on intellectual property (IP) rights to stay innovative and competitive. Without these protections, companies risk losing the chance to profit from their discoveries. Managing a strong IP portfolio helps maximize research and development (R&D) investments, open doors to licensing deals, and keep drugs on the market longer. Still, this field faces many hurdles, including tough patent laws worldwide and changing regulations. At the same time, emerging opportunities can give companies a competitive edge if they master IP management. Understanding Intellectual Property Rights in Pharmaceuticals What Are Intellectual Property Rights? IP rights are legal tools that protect creations and ideas. In pharma, they help companies control and profit from their inventions for a certain time. Types of IP relevant to drugs include patents, trademarks, trade secrets, and data exclusivity. Each has a role in defending the company’s i...
Post a Comment
Read more

An Overview of Brazil Patent litigation

  An Overview of Brazil Patent litigation Brazil plays a crucial role in Latin America's intellectual property landscape, particularly when it comes to patent litigation. The country's strong legal framework, governed by the Industrial Property Act, creates an environment where patents can be protected and enforced effectively. The Brazilian patent system serves as a vital mechanism for: Protecting innovative technologies Securing market advantages Fostering economic development Promoting technological advancement For businesses and inventors, understanding Brazil's patent litigation system is essential for success in this emerging market. The system's unique characteristics, including its bifurcated approach to handling infringement and invalidity cases, create distinct challenges and opportunities. Recent years have witnessed a surge in patent litigation cases, particularly in: Pharmaceutical sectors Technology industries Telecommunications Manufacturing This increa...
Post a Comment
Read more